Slovenia

Leading Slovenian drugmaker Krka has officially opened its Sinteza 4 active pharmaceutical ingredient (API) production facility. The EUR80mn (US$107mn) plant will allow the firm to... 2007-06-21

On the back of impressive 2006 financial results, Slovenian drugmaker Krka is looking to further penetrate emerging markets, continue to upscale its R&D capabilities, get more... 2007-02-13

Slovenia's Krka has reached an out-of-court settlement with French firm Servier over a generic version of the latter's perindopril - an ACE inhibitor for the treatment of hypertension.... 2006-11-17

Staking a prominent claim in the pharmaceutical sector experiencing the strongest growth, Slovenian firm Lek - part of Swiss firm Novartis' Sandoz generics division - has started... 2006-10-06

Frustrated at the lack of opportunities in its home market, Slovenian firm Krka is planning a concerted promotional campaign in Romania ahead of EU accession next year, which is expected... 2006-09-28

Outperforming its competitors, Slovenia firm Lek - part of the generics division of Swiss company Sandoz - has released financial results for the first half of 2006 in which sales... 2006-07-25